BioSpace News Archive

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today launched its innovative arterial femoral cannula, Bi-Flow, designed to prevent limb ischemia during cardiac surgery.

The leading provider of dermatology services in the Northeast adds two new locations in Orange County, New York to their practice.

The Parkinson’s Foundation is pleased to announce the launch of PD GENEration: Mapping the Future of Parkinson’s Disease, a first-of-its-kind national initiative that offers free genetic testing for clinically relevant Parkinson’s-related genes and free genetic counseling to help participants better understand their results.

According to Technavio Research Report “Alcoholic Hepatitis Treatment Market by type (corticosteroids, xanthine derivatives, and others), and geographic regions (North America, Europe, Asia, and ROW) is witnessed to grow by USD 570 million, at a CAGR of 6% from 2019 to 2023”.

Partners with leading European venture capital firms to build breakthrough genomics startups

Collaboration aims to discover and develop novel medicines that modulate G protein-coupled receptor (GPCR) targets across a range of diseases

Biotage follows up the strong first quarter with yet another record quarter concerning sales and earnings.

Organoids Grown in Microfluidic Device May Help CF Patients with Diabetes

FDA-approved CAR T-cell therapy fuels investor funding of the first-ever t-cell cryopreservation startup

Empire Medical Training™ is proud to announce they will continue to offer courses at New York’s Columbia University Irving Medical School and has added an additional site, Chicago’s Rosalind Franklin University School of Medicine and Science, for Advanced Facial Anatomy Cadaver – Aesthetics Training Workshops.